{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:32:16Z","timestamp":1791232336000,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.dsx.2022.102512","type":"journal-article","created":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T02:27:28Z","timestamp":1653618448000},"page":"102512","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Comparison of COVID-19 outcomes in patients with Type 1 and Type 2 diabetes: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1941-4399","authenticated-orcid":false,"given":"Arman","family":"Shafiee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Mobin","family":"Teymouri Athar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Nassar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niloofar","family":"Seighali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dlnya","family":"Aminzade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Payam","family":"Fattahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Rahmannia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Ahmadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.dsx.2022.102512_bib1","article-title":"A\u00a0comprehensive literature review on the clinical presentation, and management of the pandemic Coronavirus disease 2019 (COVID-19)","volume":"12","author":"Kakodkar","year":"2020","journal-title":"Cureus"},{"key":"10.1016\/j.dsx.2022.102512_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2020.108220","article-title":"Lack of type 1 diabetes involvement in SARS-COV-2 population: only a particular coincidence?","volume":"164","author":"Pitocco","year":"2020","journal-title":"Diabetes Res Clin Pract"},{"issue":"10228","key":"10.1016\/j.dsx.2022.102512_bib3","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/S0140-6736(20)30371-8","article-title":"Full spectrum of COVID-19 severity still being depicted - authors' reply","volume":"395","author":"Gu","year":"2020","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.dsx.2022.102512_bib4","doi-asserted-by":"crossref","first-page":"182","DOI":"10.5501\/wjv.v10.i4.182","article-title":"Current systematic reviews and meta-analyses of COVID-19","volume":"10","author":"Nassar","year":"2021","journal-title":"World J Virol"},{"issue":"8","key":"10.1016\/j.dsx.2022.102512_bib5","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1007\/s42399-020-00363-4","article-title":"Comorbidity and its impact on patients with COVID-19","volume":"2","author":"Sanyaolu","year":"2020","journal-title":"SN Compr Clin Med"},{"issue":"2","key":"10.1016\/j.dsx.2022.102512_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.dsx.2022.102406","article-title":"Antibody response following SARS-CoV-2 vaccination among patients with type 2 diabetes mellitus: a systematic review","volume":"16","author":"Soetedjo","year":"2022","journal-title":"Diabetes Metabol Syndr"},{"issue":"13","key":"10.1016\/j.dsx.2022.102512_bib7","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1001\/jama.2020.2648","article-title":"Characteristics of and important lessons from the Coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese center for disease control and prevention","volume":"323","author":"Wu","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.dsx.2022.102512_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.649525","article-title":"COVID-19 and diabetes: understanding the interrelationship and risks for a severe course","volume":"12","author":"Landstra","year":"2021","journal-title":"Front Endocrinol"},{"issue":"1","key":"10.1016\/j.dsx.2022.102512_bib9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00125-018-4711-2","article-title":"Global trends in diabetes complications: a review of current evidence","volume":"62","author":"Harding","year":"2019","journal-title":"Diabetologia"},{"issue":"8","key":"10.1016\/j.dsx.2022.102512_bib10","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1136\/archdischild-2014-307654","article-title":"Chronic comorbidities in children with type 1 diabetes: a population-based cohort study","volume":"100","author":"Fazeli Farsani","year":"2015","journal-title":"Arch Dis Child"},{"issue":"4","key":"10.1016\/j.dsx.2022.102512_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.dsx.2022.102473","article-title":"The potential use of urinary transferrin, urinary adiponectin, urinary Retinol Binding Protein, and serum zinc alpha 2 glycoprotein levels as novel biomarkers for early diagnosis of diabetic nephropathy: a case-control study","volume":"16","author":"Kamel","year":"2022","journal-title":"Diabetes Metabol Syndr"},{"issue":"1","key":"10.1016\/j.dsx.2022.102512_bib12","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.dsx.2021.02.009","article-title":"The association between COVID-19 and type 1 diabetes mellitus: a systematic review","volume":"15","author":"Nassar","year":"2021","journal-title":"Diabetes Metabol Syndr"},{"issue":"1","key":"10.1016\/j.dsx.2022.102512_bib13","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s13098-020-00586-4","article-title":"Severity and mortality of COVID 19 in patients with diabetes, hypertension and cardiovascular disease: a meta-analysis","volume":"12","author":"de Almeida-Pititto","year":"2020","journal-title":"Diabetol Metab Syndrome"},{"key":"10.1016\/j.dsx.2022.102512_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2021.108936","article-title":"Is diabetes mellitus a wrongdoer to COVID-19 severity?","volume":"178","author":"Sarkar","year":"2021","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.dsx.2022.102512_bib15","series-title":"Cochrane handbook for systematic reviews of interventions","author":"Higgins","year":"2019"},{"key":"10.1016\/j.dsx.2022.102512_bib16","series-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","first-page":"372","author":"Page","year":"2021"},{"issue":"1","key":"10.1016\/j.dsx.2022.102512_bib17","first-page":"7","article-title":"Methodological quality (risk of bias) assessment tools for primary and secondary medical studies: what are they and which is better?","volume":"7","author":"Ma","year":"2020","journal-title":"Mil Med Res"},{"issue":"2","key":"10.1016\/j.dsx.2022.102512_bib18","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/dom.14256","article-title":"COVID-19 fatality prediction in people with diabetes and prediabetes using a simple score upon hospital admission","volume":"23","author":"Sourij","year":"2021","journal-title":"Diabetes Obes Metabol"},{"key":"10.1016\/j.dsx.2022.102512_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.lanepe.2021.100105","article-title":"Severe COVID-19 in people with type 1 and type 2 diabetes in Sweden: a nationwide retrospective cohort study","volume":"4","author":"Rawshani","year":"2021","journal-title":"Lancet Regional Health-Europe"},{"issue":"4","key":"10.1016\/j.dsx.2022.102512_bib20","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1530\/EC-20-0567","article-title":"Effect of COVID-19 on the clinical course of diabetic ketoacidosis (DKA) in people with type 1 and type 2 diabetes","volume":"10","author":"Kempegowda","year":"2021","journal-title":"Endocrine connections"},{"issue":"10","key":"10.1016\/j.dsx.2022.102512_bib21","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S2213-8587(20)30271-0","article-title":"Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study","volume":"8","author":"Holman","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"10.1016\/j.dsx.2022.102512_bib22","doi-asserted-by":"crossref","first-page":"526","DOI":"10.2337\/dc20-2260","article-title":"COVID-19 severity is tripled in the diabetes community: a prospective analysis of the pandemic's impact in type 1 and type 2 diabetes","volume":"44","author":"Gregory","year":"2021","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.dsx.2022.102512_bib23","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S2213-8587(21)00089-9","article-title":"Associations between body-mass index and COVID-19 severity in 6.9 million people in England: a prospective, community-based, cohort study","volume":"9","author":"Gao","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.dsx.2022.102512_bib24","series-title":"Higher rate of COVID-19 mortality in patients with type 1 than type 2 diabetes: a nationwide study","author":"Demirci","year":"2022"},{"issue":"10","key":"10.1016\/j.dsx.2022.102512_bib25","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S2213-8587(20)30272-2","article-title":"Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study","volume":"8","author":"Barron","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"10.1016\/j.dsx.2022.102512_bib26","first-page":"87","article-title":"Higher rate of COVID-19 mortality in patients with type 1 than type 2 diabetes: a nationwide study","volume":"73","author":"Demirci","year":"2022","journal-title":"Endokrynol Pol"},{"issue":"2","key":"10.1016\/j.dsx.2022.102512_bib27","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S2213-8587(20)30405-8","article-title":"Risks of and risk factors for COVID-19 disease in people with diabetes: a cohort study of the total population of Scotland","volume":"9","author":"McGurnaghan","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"11","key":"10.1016\/j.dsx.2022.102512_bib28","article-title":"Phenotypic characteristics and development of a hospitalization prediction risk score for outpatients with diabetes and COVID-19: the DIABCOVID study","volume":"9","author":"Lasbleiz","year":"2020","journal-title":"J\u00a0Clin Med"},{"issue":"6","key":"10.1016\/j.dsx.2022.102512_bib29","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.11182","article-title":"Underlying medical conditions associated with severe COVID-19 illness among children","volume":"4","author":"Kompaniyets","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"2","key":"10.1016\/j.dsx.2022.102512_bib30","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/dom.14256","article-title":"COVID-19 fatality prediction in people with diabetes and prediabetes using a simple score upon hospital admission","volume":"23","author":"Sourij","year":"2021","journal-title":"Diabetes Obes Metabol"},{"issue":"7","key":"10.1016\/j.dsx.2022.102512_bib31","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.2337\/dc20-0598","article-title":"Clinical characteristics and risk factors for mortality of COVID-19 patients with diabetes in wuhan, China: a two-center, retrospective study","volume":"43","author":"Shi","year":"2020","journal-title":"Diabetes Care"},{"issue":"25","key":"10.1016\/j.dsx.2022.102512_bib32","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1056\/NEJM199912163412507","article-title":"Infections in patients with diabetes mellitus","volume":"341","author":"Joshi","year":"1999","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.dsx.2022.102512_bib33","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1007\/s00125-021-05522-3","article-title":"Diabetes and the risk of hospitalisation for infection: the Atherosclerosis Risk in Communities (ARIC) study","volume":"64","author":"Fang","year":"2021","journal-title":"Diabetologia"},{"key":"10.1016\/j.dsx.2022.102512_bib34","article-title":"Severe COVID-19 in people with type 1 and type 2 diabetes in Sweden: a nationwide retrospective cohort study","volume":"4","author":"Rawshani","year":"2021","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.dsx.2022.102512_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcte.2021.100271","article-title":"SARS-CoV-2 infection in hospitalized children with type 1 and type 2 diabetes","volume":"26","author":"Trieu","year":"2021","journal-title":"Journal of clinical & translational endocrinology"},{"key":"10.1016\/j.dsx.2022.102512_bib36","article-title":"The evolution of diabetic ketoacidosis: an update of its etiology, pathogenesis and management","volume":"65","author":"Nyenwe","year":"2015","journal-title":"Metabolism"},{"issue":"2","key":"10.1016\/j.dsx.2022.102512_bib37","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1136\/ebmental-2019-300129","article-title":"Challenges in meta-analyses with observational studies","volume":"23","author":"Metelli","year":"2020","journal-title":"Evid Base Ment Health"}],"container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402122001266?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402122001266?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T09:19:18Z","timestamp":1761729558000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1871402122001266"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S1871402122001266"],"URL":"https:\/\/doi.org\/10.1016\/j.dsx.2022.102512","relation":{},"ISSN":["1871-4021"],"issn-type":[{"value":"1871-4021","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of COVID-19 outcomes in patients with Type 1 and Type 2 diabetes: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolic Syndrome: Clinical Research & Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dsx.2022.102512","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Diabetes India. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102512"}}